JP2009545560A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545560A5
JP2009545560A5 JP2009522247A JP2009522247A JP2009545560A5 JP 2009545560 A5 JP2009545560 A5 JP 2009545560A5 JP 2009522247 A JP2009522247 A JP 2009522247A JP 2009522247 A JP2009522247 A JP 2009522247A JP 2009545560 A5 JP2009545560 A5 JP 2009545560A5
Authority
JP
Japan
Prior art keywords
oxycodone
disintegrating tablet
orally disintegrating
salt
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009522247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009545560A (ja
JP5421775B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/057912 external-priority patent/WO2008015220A1/en
Publication of JP2009545560A publication Critical patent/JP2009545560A/ja
Publication of JP2009545560A5 publication Critical patent/JP2009545560A5/ja
Application granted granted Critical
Publication of JP5421775B2 publication Critical patent/JP5421775B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009522247A 2006-08-04 2007-07-31 オキシコドンを含む顆粒及び口腔内崩壊錠剤 Expired - Fee Related JP5421775B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82144906P 2006-08-04 2006-08-04
US60/821,449 2006-08-04
PCT/EP2007/057912 WO2008015220A1 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone

Publications (3)

Publication Number Publication Date
JP2009545560A JP2009545560A (ja) 2009-12-24
JP2009545560A5 true JP2009545560A5 (enExample) 2013-01-31
JP5421775B2 JP5421775B2 (ja) 2014-02-19

Family

ID=38752477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009522247A Expired - Fee Related JP5421775B2 (ja) 2006-08-04 2007-07-31 オキシコドンを含む顆粒及び口腔内崩壊錠剤

Country Status (15)

Country Link
US (1) US8465776B2 (enExample)
EP (1) EP2046285B1 (enExample)
JP (1) JP5421775B2 (enExample)
KR (1) KR101445757B1 (enExample)
CN (1) CN101534792B (enExample)
AU (1) AU2007280470B2 (enExample)
BR (1) BRPI0714514B8 (enExample)
CA (1) CA2659122C (enExample)
EA (1) EA017832B1 (enExample)
ES (1) ES2667944T3 (enExample)
IL (1) IL196741A (enExample)
MX (1) MX2009001294A (enExample)
NZ (1) NZ574544A (enExample)
WO (1) WO2008015220A1 (enExample)
ZA (1) ZA200900640B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
ATE462416T1 (de) * 2006-08-04 2010-04-15 Ethypharm Sa Mehrschichtige im mund zerfallende tablette
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
DK2356989T3 (en) * 2008-10-24 2018-05-07 Toray Industries Stable tablet containing 4,5-epoxymorphinane derivative
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
US20110150989A1 (en) * 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
US9198861B2 (en) * 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
WO2012023030A2 (en) * 2010-08-18 2012-02-23 Purdue Pharma L.P. Vacuum avoiding packaging systems and methods thereof
CN102178657B (zh) * 2011-04-11 2017-05-31 浙江华海药业股份有限公司 一种奥氮平口腔崩解片
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9056057B2 (en) 2012-05-03 2015-06-16 Kala Pharmaceuticals, Inc. Nanocrystals, compositions, and methods that aid particle transport in mucus
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
US9730885B2 (en) 2012-07-12 2017-08-15 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
KR101340733B1 (ko) * 2012-12-31 2013-12-12 (주) 에프엔지리서치 신규한 마이크로그래뉼 제형
EP2801349A1 (en) 2013-05-06 2014-11-12 Siegfried AG Oral Pharmaceutical Formulation
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
GR1008992B (el) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
JP6905972B2 (ja) * 2016-02-23 2021-07-21 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
JP6915258B2 (ja) * 2016-10-21 2021-08-04 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
KR102120720B1 (ko) * 2018-07-16 2020-06-10 연성정밀화학(주) 날푸라핀 함유 구강붕해정
CN109512796A (zh) * 2018-12-26 2019-03-26 甘肃普安制药股份有限公司 一种氨酚羟考酮胶囊填充方法
US12589083B2 (en) 2019-05-07 2026-03-31 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
CN113842376B (zh) * 2020-06-28 2024-10-11 齐鲁制药有限公司 一种含有利培酮的药物组合物和口溶膜剂及制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
CA2128820A1 (en) 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP1058538B9 (en) 1998-03-06 2013-01-02 Aptalis Pharma S.r.l. Fast disintegrating tablets
ES2237121T3 (es) * 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
AU753476B2 (en) * 1998-11-25 2002-10-17 Cima Labs, Inc. Taste masking rapid release coating system
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
DK1416842T3 (da) * 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
AU2003220290B2 (en) * 2002-03-14 2007-06-14 Euro-Celtique S.A. Naltrexone hydrochloride compositions
FR2850576B1 (fr) 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
US8900637B2 (en) * 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
ATE462416T1 (de) * 2006-08-04 2010-04-15 Ethypharm Sa Mehrschichtige im mund zerfallende tablette

Similar Documents

Publication Publication Date Title
JP4969586B2 (ja) マルチプルユニット型徐放性経口製剤およびその製造方法
CN101711752B (zh) 一种苯并异噁唑类衍生物的控释制剂及其制备方法
CN1988891B (zh) 包衣片制剂和方法
JP5199084B2 (ja) 胃保持型製剤およびそれらの製造方法
EP2275093A2 (en) Pharmaceutical formulation
JP2012153724A5 (enExample)
JP2010511663A5 (enExample)
AU2015349896B2 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
JP2011502140A (ja) トルテロジンの制御放出型医薬組成物
US20120003307A1 (en) Levetiracetam controlled release composition
JP2007507491A (ja) 徐放性製剤
CN105338970A (zh) 包含他达拉非和坦洛新的药物胶囊复合制剂
CN101854921B (zh) 用于口服施用ppi的药物制剂
JP2004522780A5 (enExample)
CN101411702A (zh) 盐酸奈福泮萘普生钠复方缓释制剂及其制备方法
KR101175816B1 (ko) 경구 서방성 정제
RU2019109050A (ru) Композиции тезофензина
CN1332668C (zh) 千金藤素缓释制剂
WO2014096983A1 (en) Stable pharmaceutical compositions of saxagliptin or salts thereof
JP2013536832A (ja) ミルナシプランの制御放出医薬組成物
WO2014007777A1 (en) Combined capsule formulations of nsaids
CN102144985A (zh) 一种氯化钾单室渗透泵控释片及其制备方法
JP4696210B2 (ja) イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
CN101596158B (zh) 一种对乙酰氨基酚、伪麻黄碱和右美沙芬的复方缓释制剂
CN101259112A (zh) 盐酸沙格雷酯单层渗透泵控释制剂及其制备方法